18 F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) is a less invasive diagnostic tool and promising in detecting gastrointestinal lesions of pediatric inflammatory bowel disease (IBD) patients. Co-registration of low-dose computed tomography (CT) could lead to improvements in the assessment of disease. Therefore, this retrospective study evaluates the value of PET ± CT in pediatric IBD patients.
Introduction
Inflammatory bowel disease (IBD) is composed of two major disorders: ulcerative colitis (UC) and Crohn's disease (CD). Incidence rates of both CD and UC in children (< 18 years of age) reported in the past decade varies between 1 and 9 per 100 000 in CD patients and between 0 and 5 per 100 000 in UC patients. CD is becoming the predominant form of IBD in developed countries [1] . Approximately 25% of IBD patients have the onset of their disease during childhood and adolescence, and the incidence of pediatric IBD seems to be increasing [2] . On average the diagnostic latency in Germany is [16] [17] [18] [19] [20] [21] [22] months and the resulting delay in treatment often results in retardation of growth and development [3] .
IBD in children is characterized by frequent relapses of disease activity of variable duration and intensity. Evaluation of the nature, extent, and severity of the intestinal inflammation is necessary for the determination of disease severity and for institution of appropriate therapy. The diagnostic workup in pediatric patients with suspected IBD includes laboratory testing (blood and/or stool tests), upper endoscopy, colonoscopy (including asservation of multiple biopsies and histopathologic evaluation), and ultrasound (US). Several imaging studies exist, which offer advantages in the diagnosis, follow-up, and management of CD and UC [4] . These include dynamic computed tomography (CT) scanning, magnetic resonance imaging (MRI), hydro MRI, nuclear medicine examinations (e.g. technetium-labeled white blood cell scintigraphy), and barium-contrasted small bowel follow through [5] . However, there are a number of limitations to all of these imaging modalities that diminish their effectiveness in mapping disease site and activity. At present, mucosal inflammation is best assessed by endoscopic findings, histologic abnormalities, and radiologic features. As young children are often afraid of and/or uncooperative with invasive procedures, general anesthesia is often indicated to permit comprehensive assessment of the according investigation. Furthermore, endoscopic evaluation is time-consuming and requires extended fasts and incriminatory bowel preparation. Furthermore, endoscopy is sometimes incomplete because of inaccessible bowel segments and assesses only superficial lesions, although deeper parts of the intestinal wall may be affected too. Therefore, a sensitive and less invasive examination is needed to detect inflammatory changes, to evaluate the exact activity and location of IBD along the gastrointestinal tract (GIT), and to guide therapy, which has to balance the risks of under and overtreatment. 18 F-fluorodeoxyglucose-positron emission tomography ( 18 F-FDG-PET) exploits the high-glucose consumption of activated white blood cells to identify areas of inflammation. It is less invasive and requires no extensive prior bowel preparation. Thus, this technique is promising in pediatric patients for detecting gastrointestinal lesions of IBD. Although earlier studies have shown good sensitivity and specificity for 18 F-FDG-PET in detecting the ongoing inflammatory processes in the GIT in adults [6] [7] [8] and children [3, 5, [9] [10] [11] , the combined application with CT in adults leads to promising improvements in the assessment of affected areas [12] [13] [14] [15] [16] [17] [18] . Co-registration of PET and CT data improved the analysis of FDG uptake by avoiding confusion between abnormal focal uptake and physiologic activity. At present, there are no published data available regarding the assessment of pediatric IBD with combined 18 F-FDG-PET and CT (Table 1) . We hypothesized that the combined examination with PET and CT could lead to improvements in the diagnostic assessment of pediatric IBD. Therefore, the aim of this study was to assess the value of combined 18 F-FDG-PET and CT in children (< 18 years of age) with IBD and to compare it with conventional diagnostic tools (endoscopy with histology, US).
Patients and methods

Patients
Forty-five patients were enrolled into this retrospective study. Children (18 females, 27 males, age: 3.7-16.7 years, median 13.2 years) presenting with diagnosis of CD (n = 35) and UC (n = 10) of unclear disease activity were examined with 18 . Within 2 days (median, range: from 27 days before to 2 days after PET ± CT) of the endoscopic procedure, 24 patients underwent 18 F-FDG-PET and 21 patients underwent scans combining 18 F-FDG-PET with low-dose CT. Body weight and height, C-reactive protein, erythrocyte sedimentation rate, leukocytes, and hemoglobin were measured on admission. Parents of all the patients gave informed consent. No patient with indeterminate colitis was included in this study. Exclusion criterion was a blood sugar greater than 200 mg/dl (mean 85 ± 15 mg/dl standard deviation, range: 67-140 mg/dl) and blood glucose levels were checked regularly before PET scan. However, no patients were excluded for blood glucose greater than 200 mg/dl.
Endoscopy with histology
After adequate bowel preparation, upper endoscopies and ileocolonoscopies were performed by senior endoscopists experienced in the field of IBD. Examinations were performed under general anesthesia as a standardized procedure. After written consent from the parents had been obtained, upper GIT, colon and terminal ileum were intubated and biopsy specimens of all segments were sampled. The endoscopes used were GIF-V2, CF-VI, and GIF-XP-160 (Olympus, Hamburg, Germany). For endoscopic evaluation, eight segments per patient were considered: esophagus, stomach, duodenum, terminal ileum, ascending, transversal and descending colon, and rectosigmoid. The endoscopic lesions in each segment were classified into unaffected, mild (nonulcerated lesions, erosions, or aphthoid ulcers), moderate (larger superficial ulcers), and severe lesions (deep ulcers, strictures) [19] . Histology was assessed by a senior pathologist specialized in IBD and unaware of the clinical situation with all the examinations and laboratory tests. Findings were also classified into unaffected, mild, moderate, and severe lesions.
All PET ± CT studies were performed using a dedicated full-ring PET scanner (ECAT EXACT 921/47 Siemens, Knoxville, Tennessee, USA) for FDG-PET data acquisition, and a dual-modality PET-CT scanner (Biograph Sensation 16, Siemens, Forchheim, Germany, and Hoffmann Estates, Illinois, USA) for images that may be viewed separately or in fused mode, combining morphological and functional image data. The injected activity of the radioactive tracer was adjusted according to the recommendations of the European Association of Nuclear Medicine [20, 21] . Patients fasted for at least 6 h before 3.0 MBq of 18 F-FDG per kilogram body weight were administered intravenously. After an uptake period of 60 min a low-dose CT scan with acquisition parameters adjusted for pediatric patients was performed during mild expiration for attenuation correction and location of anatomic landmarks [22, 23] . FDG calculations are based upon an adapted dosimetry protocol for children [24] , and CT calculations are based on 'CT-Expo' [25] . For PET-CT, acquisition of CT takes only a few seconds, whereas the measurement of the emission of the radioactive tracer takes 3 min per bed position. The radiation was estimated to be approximately 5-7 mSv (0.1 mSv for the CT scout view, 1.9 mSv for the low-dose CT, and 5.0 mSv for the 18 FDG-PET study). In PET, transmission scanning for attenuation correction takes 4 min, acquisition of 18 FDG activity takes 6 min. Exposure for PET was about 5-6 mSv. Evaluation of FDG-PET scans was performed by nuclear medicine physicians certified by the board and in case of combined PET-CT in addition by radiologists certified by the board. Nuclear medicine physicians and radiologists were blinded to the results of the previous endoscopic studies. We divided the GIT into nine segments (esophagus, stomach, duodenum, small bowel, terminal ileum, ascending, transversal and descending colon, and rectosigmoid) and graded relative standardized uptake values 1-4 by comparing with liver activity using a region of interest analysis, with the most abnormal area in the region used for analysis (1, no activity; 2, activity equal to liver; 3, activity greater than liver but less than grade 4; 4, activity at least three times the liver). Grades 1 and 2 were considered as negative (no inflammation), whereas grades 3 and 4 were considered as positive (significant inflammation).
Statistical analysis
Endoscopy, histology, US, and 18 F-FDG-PET ± CT were performed in a routine clinical setting, and written reports were analyzed. Various endoscopic, histologic, abdominal US, PET, and PET-CT scores were attributed to each segment explored and were compared and correlated. According to the requirements of a validation study, the score for histology served as a gold standard (no lesion, mild, moderate, severe lesion). Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for the detection of segments with endoscopical/histological lesions by PET ± CT in a patient-based and segment-based analyses were calculated.
Results
Patient-based analysis
The characteristics of the patients (n = 45) are presented in Table 2 . A complete ileocolonoscopy was possible in 25 cases; in nine patients the endoscopic exploration was stopped in the cecum, and in one case in the descending colon. In 10 patients no endoscopy was performed. Esophago-gastro-duodenoscopy was performed in 30 patients. In total, endoscopy was performed in 26 children with CD and nine patients with UC. Thirtyfour of 35 children showed endoscopic and/or histological evidence of inflammation/IBD in at least one segment of the GIT. In this group, 33 patients had (true positive) pathologic activity on PET ± CT scanning. In one case the endoscopy revealed no evidence of GIT inflammation and the PET ± CT scan was also (true) negative. One patient showed endoscopic evidence of inflammation, but the PET ± CT scan detected no abnormalities (false negative). There was no patient with abnormal PET ± CT scan and endoscopy without pathological findings (false positive). Compared with endoscopy/histology, the patient-based sensitivity and specificity was 97 and 100%, respectively (Table 3) . Including mesalazine and sulfasalazine. inflammation and 138 (55%) showed no inflammatory lesions (Table 4) . Further five of 25 ultrasonographically assessed small bowel segments showed abnormalities in terms of inflammation. Of the endoscopically/histologically affected segments the majority (60%) were located in the colon, followed by the rectosigmoid (19%), upper GIT (12%), and the terminal ileum (9%). Of the 253 segments, 77 (30%) showed mild lesions, 35 (14%) showed moderate lesions, three segments (1%) showed severe lesion and no segment showed strictures. Mild lesions were mainly located in the colon (60%), followed by the upper GIT (18%), the rectosigmoid (17%), and the terminal ileum (5%). Moderate lesions were predominantly observed in the colon (60%), followed by the rectosigmoid (26%), and terminal ileum (14%). One severe lesion was reported in terminal ileum and two in the transversal colon. Moderate and severe lesions were not reported in the upper GIT.
Comparison of conventional diagnostic studies and positron emission tomography ± computed tomography findings
One hundred and thirty (32%) segments showed increased 18 F-FDG uptake (example given in Fig. 1 ). Of these positive segments the majority (62%) were located in the colon, followed by the rectosigmoid (19%), small bowel including terminal ileum (18%), and the upper GIT (1%) ( Table 4) . Globally, 18 F-FDG-PET ± CT detected 98 of 115 affected segments and showed a sensitivity for the detection of GIT lesions of 82% (Table 5) . Among the segments abnormal on 18 F-FDG-PET ± CT, 98 of 102 showed endoscopic or ultrasonographic lesions, and among segments without lesions, 154 of 158 were also 18 F-FDG-PET ± CT negative (specificity for the detection of GIT lesions, 97%). The sensitivity for the detection of GIT lesions was higher in PET without CT (86%) compared with PET-CT (76%). The specificity for the detection of GIT lesions was slightly higher in PET alone (100%) compared with PET-CT (93%). With endoscopy/histology (upper GIT and large intestine) and abdominal US (small bowel segments) as the standard of reference 18 F-FDGPETwithout and with CT showed a bowel segment-based positive predictive value, negative predictive value, and accuracy of 100/91/94% and 90/82/85%, respectively. The sensitivity for the detection of GIT lesions was highest in transversal (100%) and descending (96%) colon, whereas the specificity was highest in the upper GIT, the small bowel, and terminal ileum (in each case 100%). Details of the segment-based analysis are given in Table 5 .
Discussion
A couple of 18 F-FDG-PET studies have already been reported in adult and pediatric IBD patients [3, [5] [6] [7] [8] [9] [10] [11] and some studies with combined 18 F-FDG-PET and CT in adult IBD patients have been reported (Table 1 ) [12] [13] [14] [15] [16] [17] [18] . To our knowledge, this study is the first on the correlation of combined 18 F-FDG-PET ± CT and clinical, endoscopic, and ultrasonographic evaluation in pediatric IBD patients. In this study we analyzed FDG-PET ± CT findings in 45 pediatric IBD patients and compared the findings of 278 GIT segments (including upper GIT, small and large intestine) with endoscopy/histology (assessment of upper GIT and large intestine) and US (assessment of the small intestine) as reference standard. In the patientbased analysis (endoscopy/histology as reference standard) sensitivity and specificity of PET ± CT were very high: 97 and 100%, respectively ( Table 3 ). The segmentbased analysis showed a sensitivity, specificity, positive predictive value, negative predictive value, and an accuracy of 82, 97, 96, 88, and 91%, respectively (Table 5 ).
In our study colonoscopy was performed in close temporal relation to PET-CT in 35 of 45 IBD patients (78%), and colonoscopy could be completed with ileal intubation in 25 of 35 cases (71%). A number of colonic segments and terminal ileum were not examined on colonoscopy for a variety of reasons, including severe disease, level of patient discomfort, inadequate sedation, insufficient bowel preparation, and technical difficulties. Furthermore, general anesthesia is often required during colonoscopy in pediatric patients and, therefore, the procedure is often deferred or declined by patients' parents. Thus, in pediatric patients conventional methods for diagnosing and re-evaluating both UC and CD are often poorly tolerated because of their In this study, the esophagus and stomach harbored only mild lesions (Table 4) , potentially leading to a reduced sensitivity and/or specificity of the PET ± CT compared with intestine-focusing studies. In addition, physiologically elevated glucose metabolism could conceal inflammatory activity. Furthermore, false negative findings in PET ± CT could result from therapeutic intervention or endoscopically/histologically described alterations with little or no acute inflammation. The bowel segmentbased analysis in IBD patients under treatment at the time of PET ± CT scan (n = 13, 29%) showed a sensitivity, specificity, positive predictive value, negative predictive value, and an accuracy of 84, 100, 100, 92, and 94% respectively. Whereas the bowel segment-based analysis in IBD patients without treatment (n = 32, 71%) at the time of PET ± CT scan showed a comparable sensitivity, specificity, positive predictive value, negative predictive value, and an accuracy of 81, 97, 95, 86, and 94% respectively. Thus, we saw no relevant differences in the sensitivity and specificity of PET ± CT in patients, who were on steroids or other immunosuppressants at the time of PET ± CT. In contrast, it is known that 18 F-FDG uptake is also seen in patients without IBD [26] , in asymptomatic patients [27] , and in (entero) colitis [28] [29] [30] . Thus, because 18 F-FDG uptake without endoscopic lesions was usually considered a false positive result of 18 F-FDG-PET ± CT, specificity of the technique is diminished, even if it might be a result of a successful therapy with remaining endoscopic alterations. Nevertheless, we found a high specificity for the detection of GIT lesions of 100% in the per patient analysis and a comparable specificity of 97% in the per-GIT segment analysis (Tables 3 and 5) . Furthermore, there were a . Whereas low-dose CT is not necessary to localize activity in the large bowel, it can be helpful to identify the location of an inflamed segment in the small bowel. Endoscopy and colonoscopy revealed moderate inflammation of the large bowel with ulcerations, vulnerable and tumid bowel walls, more pronounced in the cecum.
number of patients/GIT segments in this study who had disease recognized on PET ± CT scanning that was not appreciated on either of the other diagnostic methods. These abnormalities occurred in segments of the GIT not available to endoscopy. This suggests that PET ± CT scanning is a useful diagnostic adjunct in characterizing and localizing the disease through the GIT in pediatric IBD patients. Other radiological techniques, such as MR enteroclysis, are more useful diagnostic tools for advanced inflammatory processes with morphological alterations, like fixed bowel stenosis and fistula.
Interestingly, the combined application of FDG-PET and CT did not improve the sensitivity or specificity for the detection of GIT lesions in our pediatric IBD patients, even though the CT scanner still allowed precise location of the lesions and gave some morphologic information. One reason might be a different patient group with partially treated inflammation. Another possible reason is that in our experience, the co-registration of PET and CT is especially helpful to localize inflammatory foci in the small bowel. As this area is quite often not reached during endoscopy, a possible advantage of PET-CT over PET escapes statistical evaluation. Horsthuis et al. [31] performed a meta-analysis comparing the accuracies of US, MRI, scintigraphy, and CT in the diagnosis of IBD in adults. According to this study, the sensitivity on a per patient basis was high and not significantly different (84-93%). Mean per patient specificity estimates were 85-96%; the only significant difference in values was that between scintigraphy (85%) and US (96%). Mean per bowel segment sensitivity estimates were lower (67-77%); mean per bowel segment specificity estimates were 90-93%. CT proved to be significantly less sensitive (67%) and specific (90%) compared with scintigraphy (sensitivity and specificity 77 and 90%, respectively) and MRI (sensitivity and specificity 70 and 94%, respectively).
There are no data available concerning the assessment of pediatric IBD with FDG-PET-CT, but a couple of PET-CT studies have already been reported in adult IBD patients and have shown excellent sensitivity for detecting active bowel inflammation, but with poor specificity in some studies (Table 1 ) [12] [13] [14] [15] [16] [17] [18] . It has been suggested that the anatomic information obtained from the PET scan alone is sufficient to accurately identify active bowel segments in UC because of the high quality of the PET images. However, in patients with CD the involvement of the small intestine and surgically altered anatomy (if present) make the localization capabilities of CT imperative to provide accurate regional analysis. Thus, PET alone seems sufficient for the evaluation of UC, but PET-CT provides considerably more information over PET alone in the evaluation of CD. In our study, the bowel segment-based analysis in CD patients showed a sensitivity, specificity, positive predictive value, negative predictive value, and an accuracy of PET/PET-CT of 83/72, 100/91, 100/88, 91/78, and 94/82%, respectively. Table 5 Sensitivities and specificities of FDG-PET ± CT versus colonoscopy/histology Whereas the bowel segment-based analysis in UC patients showed a sensitivity, specificity, positive predictive value, negative predictive value, and an accuracy of PET/PET-CT of 91/91, 100/100, 100/100, 89/94, and 95/96%, respectively. Thus, the combined application of FDG-PET and CT did not improve the sensitivity or specificity for the detection of GIT lesions in our pediatric IBD patients, neither in CD patients nor in the subgroup of patients with UC. Interestingly, PET alone seems to be more reliable in pediatric patients with CD compared with the additional application of CT. These observations could be explained by differences in adult and pediatric patients with CD, given that surgically altered anatomy, stricturing and fistulating disease is less common in children. Furthermore, the comparability of the reliability of PET-CT in CD and UC patients of our study is limited as we included more CD patients (n = 35) than patients with UC (n = 10).
The diagnostic approach to a patient with known IBD presenting symptoms should include the clinical evaluation based on history (especially loose stools or bloody diarrhea, fever, abdominal pain, weight loss, perianal disease, anemia), examination (oral ulcerations, abdominal palpation, perianal involvement), and laboratory data (white blood cell and platelet count, anemia, elevated erythrocyte sedimentation rate and C-reactive protein, depressed albumin level, and blood in the stool, stool cultures). Further evaluation with endoscopic and/or radiographic procedures is appropriate if the tests described above suggest the possibility of a flare. Noninvasive imaging using PET is appropriate in differentiating between flare of IBD versus onset of a noninflammatory process causing similar symptoms in patients with known IBD, and in the early evaluation of IBD, especially in children. In addition, it has been shown that a reduction in the appropriate FDG-PET determination occurs with successful treatment of disease activity and correlates with symptom improvement. The relatively low radiation exposure of 5-7 mSv (range of approximately 1-3 years of natural exposure) is justified by the high accuracy of this approach. The exclusive registration of FDG-PET (5-6 mSv) minimizes the radiation exposure in comparison with CT co-registration (7 mSv). Although, PET may never be used widely in the primary investigation of pediatric IBD it offers an alternative investigation when conventional imaging has failed or when data of the more conventional studies are misleading. Thus, PET is partially useful in children with known IBD presenting symptoms when conventional studies (e.g. colonoscopy) are technically unsuccessful, not feasible or performing (repeated) invasive tests may not be desired or declined by pediatric patients or their parents.
Conclusion
This study is the first on the correlation of combined 18 F-FDG-PET ± CT and clinical, endoscopic and ultrasonographic evaluation in pediatric IBD patients. FDG-PET is especially suitable for the assessment of IBD in children. The radiation exposure of 3-7 mSv is justified by the accuracy of this approach. FDG-PET seems to be a reliable tool for detecting inflamed gut segments in IBD with high sensitivity and specificity. The co-registration of CT had no additional benefit. Larger (multicentre) studies with a sufficient number of patients are required to stratify according to the type of disease and the site of involvement to draw solid conclusions. Future prospective studies should explore the possibility of using a PET scoring system instead of a clinical or endoscopical score to determine local disease activity.
